Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Amyotrophic Lateral Sclerosis
Study falls short of showing efficacy of high dose vitamin E therapy
July 25th, 2005
The efficacy of high doses of the antioxidant vitamin E in slowing disease progression of amyotrophic lateral sclerosis is not shown in a study from France. "Increasing evidence has suggested that oxidative stress may be involved in the pathogenesis of amyotrophic lateral sclerosis (ALS). The antioxidant vitamin E (alpha-tocopherol) has been shown to slow down the onset and progression of the paralysis in transgenic mice expressing a mutation in the superoxide dismutase gene found in certain forms of familial ALS," researchers reported in the Journal of Neural Transmission. M. Graf and associates at the Hospital La Pitie Salpetriere in Paris...
Source: Health & Medicine Week (2005-07-25)
|
